latest news releases from the newsroom
CombiMatrix to Hold Conference Call to Discuss the Development of Array for Cancer Screening
MUKILTEO, Wash., Oct. 3, 2008 (GLOBE NEWSWIRE) -- CombiMatrix Corporation (Nasdaq:CBMX) will hold a conference call to discuss the development of its CombiMatrix Cancer Array (CCA) test for cancer screening. Dr. Amit Kumar, President and CEO of CombiMatrix will host this call and will make a short presentation, followed by Q&A. The CCA test is a cancer screening product with multi-billion dollar market potential. This product is in the R&D pipeline of CombiMatrix. This presentation will provide information about the product, its current development stage, its market potential, and other relevant information.